University of Virginia
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1819-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.virginia.edu
Reduce African-American Infant Mortality
Not Applicable
Completed
- Conditions
- Health Behavior
- Interventions
- Behavioral: Reduce Infant Mortality
- First Posted Date
- 2011-05-27
- Last Posted Date
- 2017-07-05
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 1200
- Registration Number
- NCT01361880
- Locations
- 🇺🇸
Washington Hospital Center, Washington, D.C., District of Columbia, United States
Ethanol Lock for Prevention of Central Line-Associated Blood Stream Infections
Not Applicable
- Conditions
- Central Lines in ICU Patients
- Interventions
- Other: Normal SalineOther: Ethanol 70% pharmaceutical grade
- First Posted Date
- 2011-04-29
- Last Posted Date
- 2011-04-29
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 50
- Registration Number
- NCT01344590
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Text Messaging Intervention to Improve HIV Adherence in Rural Drug Users
Not Applicable
Completed
- Conditions
- HIV Infections
- Interventions
- Behavioral: Treatment as usualBehavioral: Text messaging plus EMA
- First Posted Date
- 2011-04-28
- Last Posted Date
- 2018-02-15
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 54
- Registration Number
- NCT01343654
- Locations
- 🇺🇸
UVA Infectious Diseases Clinic, Charlottesville, Virginia, United States
A Gene by Medication Interaction to the Acute Effects of Alcohol
Phase 1
Terminated
- Conditions
- Alcohol-induced Cue-cravingAlcohol Sensitivity
- Interventions
- Drug: Placebo Comparator
- First Posted Date
- 2011-04-28
- Last Posted Date
- 2012-05-31
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 43
- Registration Number
- NCT01343628
- Locations
- 🇺🇸
Center for Addiction Research and Education, Charlottesville/ Richmond, Virginia, United States
Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects
Phase 2
Withdrawn
- Conditions
- Kidney DiseaseChronic Kidney Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-04-28
- Last Posted Date
- 2018-05-14
- Lead Sponsor
- University of Virginia
- Registration Number
- NCT01343641
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
The Impact of Fitness on Vascular Dysfunction in Adolescents With Type 1 Diabetes
- First Posted Date
- 2011-04-19
- Last Posted Date
- 2014-09-29
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 32
- Registration Number
- NCT01337947
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer
Phase 2
- Conditions
- Pancreatic Cancer
- Interventions
- Radiation: Standard Dose Acclerated Fraction Radiotherapy
- First Posted Date
- 2011-04-11
- Last Posted Date
- 2011-04-11
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 35
- Registration Number
- NCT01333332
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Pilot Study of Intensive Care Unit Continuous Glucose Monitoring
Not Applicable
- Conditions
- HyperglycemiaHypoglycemia
- Interventions
- Other: Current UVA intensive care insulin protocolOther: Current UVA intensive care insulin protocol with "brakes"
- First Posted Date
- 2011-02-23
- Last Posted Date
- 2013-01-31
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 20
- Registration Number
- NCT01301053
- Locations
- 🇺🇸
University of Virginia, Center for Diabetes Technology, Charlottesville, Virginia, United States
Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma
- First Posted Date
- 2010-12-22
- Last Posted Date
- 2016-12-16
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 4
- Registration Number
- NCT01264731
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer
- First Posted Date
- 2010-11-15
- Last Posted Date
- 2014-04-14
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 3
- Registration Number
- NCT01240824
- Locations
- 🇺🇸
University of Virginia Urology Department, Charlottesville, Virginia, United States
© Copyright 2025. All Rights Reserved by MedPath